Filter Results

Human IL-6 ELISA

Pack Size Price (₹) Add to cart
1 x 96 wells
₹16,000.00
₹15,000.00

Enzyme Immunoassay for the quantitative determination of Human IL-6 in serum, plasma and cell culture supernatant.

SKU: KB1068

In Stock

  • Details
  • Product Specifications
  • Citations
  • Documents
Interleukin-6 (IL-6) is a member of the IL-6 family. It   consists of polypeptide cytokines with a four–α-helix structure and a molecular mass of 21 to 28 kDa.
It is a pleiotropic, pro-inflammatory cytokine produced by a variety of cell types, including lymphocytes, monocytes, and fibroblasts. 
IL-6 Stimulates  acute phase reactions. These promote the activation of innate immunity, keeping tissue damage at bay. 
It also helps T-cells to differentiate early in their development. It is required for progenitor cell development, and also for T-cell and NK cell activation. In addition, it helps them to achieve pathogen lysis inside the cells.
Interleukin-6 also helps B-cells differentiate and proliferate, and promotes the formation of plasma cells from B-cells. In addition, as a growth factor for these cells, it enhances antibody release, in the form of IgA and IgG.
Interleukin-6 is also vital for the development of blood cells, whether white cells, red cells or platelets. It seems to play an important role in the development of Kaposi’s sarcoma, and multiple myeloma.


IL-6 and COVID -19:

Infection by the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) induces a dose-dependent production of IL-6 from bronchial epithelial cells. COVID-19-associated systemic inflammation and hypoxic respiratory failure can be associated with heightened cytokine release, as indicated by elevated blood levels of IL-6, C-reactive protein (CRP), D-dimer, and ferritin.It is hypothesized that modulating the levels of IL-6 or its effects may alter the course of disease.
Therefore,IL-6 is a key mediator of Cytokine release syndrome and can be used potential therapeutic target  by blocking IL-6 potentially beneficial for patients with severe inflammation in the lungs due to CRS.
There are two classes of Food and Drug Administration (FDA)-approved IL-6 inhibitors: anti-IL-6 receptor monoclonal antibodies (e.g., sarilumab, tocilizumab) and anti-IL-6 monoclonal antibodies (siltuximab). These classes of drugs have been evaluated for the management of patients with COVID-19 who have systemic inflammation.
The GENLISA™ ELISA kits are used for assessing the specific biomarker in samples analytes which may be serum, plasma and cell culture supernatant as validated with the kit. The kit employs a sandwich ELISA technique which leads to a higher specificity and increased sensitivity compared to conventional competitive ELISA kits which employ only one antibody. Double antibodies are used in this kit.
Suppliers Krishgen Biosystems
Other Specifications Sample : serum, plasma and cell culture supernatant. Detection : Quantitative
Reactivity or Species Human IL-6
Sensitivity 3.13 pg/ml
Calibrator Range 3.13-200pg/ml Please note that it is tecommended to follow the protocol/ reference values as per the kit insert / instructions for use provided with the kit and not use the one from our website, as the same is subject to changes.
Storage Condition 2-8 Deg.C
Usage For Research Use Only
Specificity Human
ELISA Type Sandwich

Topic :

Distributor

ARE YOU A

Join KRISHGEN as a verified distributor to get access to over 1 million sku’s, including reagents, biochemicals and assays. Your one stop vendor for life sciences.

Subscribe Newsletter

WE ALSO DISTRIBUTE SPECIFICALLY IN ASIA INCL. INDIA FOR

Krishgen Support